GovWire

Decision: Regulatory approval of Pfizer/BioNTech bivalent Original/Omicron booster vaccines

Medicines Healthcare Products Regulatory Agency

November 9
12:47 2022

Last updated 11/2022 - Summary of Product Characteristics - Pfizer/BioNTech bivalent vaccine - Comirnaty Original / Omicron BA.1

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email webupdates@mhra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Last updated 11/2022 - Patient Information Leaflet - Pfizer/BioNTech bivalent vaccine - Comirnaty Original / Omicron BA.1

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email webupdates@mhra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Last updated 11/2022 - Summary of Product Characteristics - Pfizer/BioNTech bivalent vaccine - Comirnaty Original / Omicron BA.4-5

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email webupdates@mhra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: